EAM
KZIA

Empery Asset Management’s Kazia Therapeutics KZIA Stock Holding History

Empery Asset Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-170,000
Closed -$1.17M – 36
2025
Q4 		$1.17M Buy
+170,000
New +$1.45M 1.03% 12

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Empery Asset Management's KZIA Position: Q1 2026 in Review

Empery Asset Management sold out of Kazia Therapeutics (KZIA) in Q1 2026, closing a stake of 170,000 shares — an estimated $1.17M sold.

Empery Asset Management first reported a position in KZIA in Q4 2025 and held it in 1 quarter. The position peaked at $1.17M in Q4 2025. 23 funds tracked by Wall St. Rank hold KZIA as of Q1 2026.

  • Empery Asset Management reported no remaining Kazia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Empery Asset Management sold 170,000 Kazia Therapeutics shares in Q1 2026, an estimated $1.17M.
  • Empery Asset Management first reported a position in Kazia Therapeutics in Q4 2025 and held it in 1 quarter.
  • Empery Asset Management's Kazia Therapeutics position peaked at $1.17M in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2026.

Based on Empery Asset Management's 13F filing for Q1 2026, filed 8 May 2026.